Get the Stockscreener App
6.35
3.08%
0.19
After Hours:
6.37
0.02
+0.31%
Teladoc Health Inc stock is traded at $6.35, with a volume of 6.73M.
It is up +3.08% in the last 24 hours and down -12.53% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$6.16
Open:
$6.2
24h Volume:
6.73M
Relative Volume:
1.07
Market Cap:
$1.13B
Revenue:
$2.54B
Net Income/Loss:
$-207.36M
P/E Ratio:
-5.3361
EPS:
-1.19
Net Cash Flow:
$151.25M
1W Performance:
-2.76%
1M Performance:
-12.53%
6M Performance:
-24.58%
1Y Performance:
-35.73%
1-Day Range:
$6.15
$6.40
1-Week Range:
$6.03
$6.51
52-Week Range:
$6.03
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.35 | 1.09B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Is Teladoc’s Expanded 24/7 Care Data Strategy a Durable Edge in Virtual Care Competition (TDOC)? - Yahoo Finance New Zealand
2 Beaten-Down Stocks That Could Sink Even More in 2026 - Finviz
Sarepta and Teladoc Face Major Challenges, Stock Outlook Dim - Intellectia AI
Sarepta Therapeutics and Teladoc Health Face Major Challenges, 2026 Outlook Dismal - Intellectia AI
2 Beaten-Down Stocks That Could Sink Even More in 2026 - The Motley Fool
Teladoc Health Sees Unusually Large Options Volume (NYSE:TDOC) - MarketBeat
Teladoc Health: Why Low Valuation Doesn't Equal A 'Buy' (Rating Downgrade) (NYSE:TDOC) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Teladoc (TDOC) and Immunome (IMNM) - The Globe and Mail
Teladoc Health shares tumble for seven consecutive sessions - MSN
Teladoc Health (TDOC) Faces Decline Amid Analyst Optimism - GuruFocus
Teladoc Health (TDOC) Shares Drop for Seven Consecutive Sessions, Losing Nearly 16% - Intellectia AI
Teladoc and EverQuote Shares Plummet, What You Need To Know - Finviz
(TDOC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
3 Reasons to Avoid TDOC and 1 Stock to Buy Instead - Finviz
Hims & Hers Expands Platform-Led Access to Digital Healthcare - The Globe and Mail
Analyst Downgrade: Can Teladoc Health Inc beat the S P 500Entry Point & Reliable Price Breakout Alerts - baoquankhu1.vn
Teladoc stock hits 52-week low at $6.34 By Investing.com - Investing.com Nigeria
Aug Movers: What is Teladoc Health Incs TAM Total Addressable MarketWeekly Profit Recap & Real-Time Market Trend Scan - baoquankhu1.vn
Teladoc Health (NYSE:TDOC) Reaches New 52-Week LowTime to Sell? - MarketBeat
Teladoc stock hits 52-week low at $6.34 - Investing.com
Lobbying Update: $60,000 of TELADOC HEALTH INC lobbying was just disclosed - Quiver Quantitative
Is Teladoc’s Data‑Driven 24/7 Care Upgrade Quietly Reframing Its Integrated Care Story (TDOC)? - Sahm
Teladoc Health 24 7 Care Upgrade Prompts Fresh Look At Apparent Valuation Discount - Sahm
Assessing Teladoc Health (TDOC) Valuation After Recent Share Price Volatility - Yahoo Finance
Retail Trends: Can Teladoc Health Inc beat the S P 5002025 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn
JPM 2026, Day 4: Clover predicts a profit, plans tech investments - Modern Healthcare
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - sharewise.com
Aug Weekly: How Teladoc Health Inc stock reacts to bond yields2025 Stock Rankings & Fast Entry Momentum Alerts - moha.gov.vn
Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Challenges with a 25% Potential Upside - DirectorsTalk Interviews
Telemedicine Market to Reach US$ 488.89 Billion by 2033 at 16.8% - openPR.com
Reprint-MH25094TeledocHealth - Modern Healthcare
Teladoc Health Unveils New Capabilities to Treat More Conditions and Detect Care Gaps Earlier - MedCity News
Aug Swings: How volatile is Teladoc Health Inc stockMarket Growth Report & Expert Verified Movement Alerts - baoquankhu1.vn
Teladoc Health Unveils ‘Prism-Powered’ 24/7 Virtual Urgent Care for 100M Americans - HIT Consultant
Teladoc Health Inc: Best in Business 2025 - Modern Healthcare News
Barclays initiates coverage on Teladoc (TDOC) with equal weight at $8.50 - MSN
Teladoc Health Launches Enhanced 24/7 Care Service to Broaden Virtual Urgent Care Capabilities - Quiver Quantitative
Teladoc Health Launches Enhanced 24/7 Care Service - Bluefield Daily Telegraph
Teladoc Health, Inc. $TDOC Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Teladoc Health Buys Catapult Health In $65M Acquisition - MSN
Why Is Teladoc (TDOC) Down 14.8% Since Last Earnings Report? - MSN
Teladoc Health Inc. (TDOC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Citigroup Lowers Target Price for Teladoc Health (TDOC) to $9.00 - GuruFocus
Citigroup Cuts Teladoc Health (NYSE:TDOC) Price Target to $9.00 - MarketBeat
(TDOC) Risk Channels and Responsive Allocation - Stock Traders Daily
Is Teladoc Health Inc. stock supported by free cash flowEarnings Summary Report & Long-Term Safe Investment Ideas - ulpravda.ru
Why Teladoc Health Inc. stock could benefit from AI revolutionPortfolio Profit Report & Expert-Curated Trade Recommendations - ulpravda.ru
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell? - Finviz
Why Teladoc (TDOC) Dipped More Than Broader Market Today - sharewise.com
Can Teladoc (TDOC) Use AI And Partnerships To Offset BetterHelp Weakness And Competitive Pressure? - Yahoo Finance
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):